Vigabatrin For Solution
Product Images NDC 69238-1425

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Vigabatrin (NDC 69238-1425). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Ny Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Formula (Vigabatrin For Oral Solution 1)

Chemical structure of vigabatrin showing its molecular formula with an amino group, a vinyl group, and a carboxylic acid group attached to a carbon chain.*

FDA Label Image

Figure E (Vigabatrin For Oral Solution 10)

An instructional image showing a dosing syringe with volume markings from 1 mL to 10 mL, with a hand holding and pointing to the 10 mL line. The image likely corresponds to measuring a dose of the Vigabatrin oral solution at 500 mg per 1 mL strength by Amneal Pharmaceuticals NY LLC.*

FDA Label Image

Figure F (Vigabatrin For Oral Solution 11)

An instructional image showing a hand holding an oral syringe above an empty glass, presumably demonstrating measuring or administering a liquid medication dose, relevant to oral solution dosage forms like Vigabatrin 500 mg/1.*

FDA Label Image

Figure G (Vigabatrin For Oral Solution 12)

A black and white photo showing a hand holding a spoon stirring a clear liquid in a transparent glass. The image likely represents preparation or administration of an oral solution, such as a medication dose.*

FDA Label Image

Figure H (Vigabatrin For Oral Solution 13)

A photographic illustration showing two hands holding a graduated dosing syringe above an empty clear glass cup. The syringe has visible measurement markings, indicating use for measuring and administering oral liquid medication.*

FDA Label Image

Figure I (Vigabatrin For Oral Solution 14)

An illustration showing a close-up of a hand holding an oral dosing syringe with measurement markings in milliliters, indicating its use for administering a liquid solution of Vigabatrin 500 mg/1 mL orally.*

FDA Label Image

Figure J (Vigabatrin For Oral Solution 15)

FDA Label Image

1 (Vigabatrin For Oral Solution 16)

Label for Vigabatrin for Oral Solution, USP 500 mg by Amneal Pharmaceuticals NY LLC. The label indicates it is a single packet of oral solution with instructions for use, storage conditions at 20 to 25°C, and a barcode. It is marked Rx only with directions to mix each packet with 10 mL of water and to discard unused portions immediately.*

FDA Label Image

Carton (Vigabatrin For Oral Solution 17)

Packaging label for Vigabatrin for Oral Solution, USP, 500 mg per packet, presented as 50 packets. The label shows the product name, strength, dosage form, and directions for use, including mixing each packet with 10 mL of water before administration. The labeler is Amneal Pharmaceuticals NY LLC, with storage instructions at 20° to 25°C (68° to 77°F).*

FDA Label Image

1 (Vigabatrin For Oral Solution 2)

A line graph titled 'Percent Reduction from Baseline in Seizure Frequency' showing the percentage reduction in seizure frequency on the y-axis and percentage of patients on the x-axis. The graph compares seizure frequency changes among patients receiving placebo and varying doses of Vigabatrin (1g/day, 3g/day, 6g/day). Arrows indicate directions for improvement and worsening in seizure frequency.*

FDA Label Image

2 (Vigabatrin For Oral Solution 3)

A line graph titled 'Percent Reduction from Baseline in Seizure Frequency' comparing placebo and 3g/day Vigabatrin (VGB). The vertical axis shows percent reduction in seizure frequency from -100% to 100%, with labels for Improvement, No Change, and Worsening. The horizontal axis indicates the percent of patients from 100% to 0%. Two lines represent the cumulative distribution of patients for each treatment group.*

FDA Label Image

Figure (1)

Vigabatrin 500 mg/1 oral solution label from Amneal Pharmaceuticals NY LLC is shown alongside two dosing syringes, a pair of scissors, and two clear drinking glasses, one containing water and the other empty with a teaspoon inside.*

FDA Label Image

Figure (2)

An instructional diagram of a 10 mL oral syringe with labeled parts including tip, dosage indicators marked in mL from 1 to 10, barrel, bottom of white plunger, and plunger. The syringe is depicted horizontally on a white background.*

FDA Label Image

Figure A (Vigabatrin For Oral Solution 6)

An image showing a hand pouring the contents of a single-dose sachet labeled Vigabatrin Oral Solution USP into a clear glass, illustrating the preparation of an oral solution dose.*

FDA Label Image

Figure B (Vigabatrin For Oral Solution 7)

FDA Label Image

Figure C (Vigabatrin For Oral Solution 8)

An image showing a hand holding a syringe marked with volume measurements submerged in a glass of clear liquid, illustrating the preparation or measurement of an oral solution, consistent with a medication dosing context.*

FDA Label Image

Figure D (Vigabatrin For Oral Solution 9)

An image of a hand holding an oral dosing syringe with visible volume markings for measuring liquid medication. The syringe is being prepared for administering Vigabatrin oral solution, 500 mg/1, by Amneal Pharmaceuticals NY LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.